LINC01785

Across TCGA pan-cancer cohorts, LINC01785 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01785 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC01785 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01785 expression acts as an unfavorable survival marker, although some lineages such as UVM and HNSC show a favorable association.

BLCA, LUSC, and UVM are the cancer types where LINC01785 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.109	0.349	.008	48	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	48	view →
UVM	OS	Tertile	II,III,IV	0.819	0.483	.006	42	view →
READ	DFS	Tertile	All	0.084	0.845	<.001	36	view →
SKCM	OS	Tertile	All	0.222	0.335	.007	30	view →
THCA	OS	Tertile	II,III,IV	0.923	0.976	.002	27	view →
HNSC	OS	Tertile	All	0.869	0.736	.012	27	view →
LGG	DFS	Tertile	All	0.518	0.330	<.001	26	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
LIHC	OS	Tertile	All	0.655	0.800	.028	12	view →
KIRP	OS	Tertile	All	0.816	0.926	.007	11	view →
MESO	DFS	Median	All	0.597	0.294	.019	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC01785–BLCA (DFS)

Open the BLCA breakdown →